Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients
Author(s) -
Siddhesh Kamat,
Steve Offord,
John P. Docherty,
Jay Lin,
Anna Eramo,
Ross A. Baker,
Benjamín Gutiérrez,
Craig N. Karson
Publication year - 2015
Publication title -
drugs in context
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.262
H-Index - 18
eISSN - 1745-1981
pISSN - 1740-4398
DOI - 10.7573/dic.212267
Subject(s) - medicaid , medicine , schizophrenia (object oriented programming) , antipsychotic , psychiatry , emergency medicine , health care , economics , economic growth
Evaluate utilization of inpatient healthcare resources and associated costs after 12 months of treatment using long-acting injectable (LAI) antipsychotic medications among a large sample of Medicaid-insured patients categorized by different age groups.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom